259
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Review of radiation therapy services for neurofibromatosis (NF2) patients in England

&
Pages 16-19 | Received 29 Dec 2012, Accepted 26 Oct 2013, Published online: 19 Dec 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianfei Long, Yu Zhang, Xiang Huang, Junwei Ren, Ping Zhong & Bin Wang. (2021) A Review of Drug Therapy in Vestibular Schwannoma. Drug Design, Development and Therapy 15, pages 75-85.
Read now

Articles from other publishers (6)

Jianwei Shi, Dafeng Lu, Ruxin Gu, Huaping Sun, Li Yu, Ruihan Pan & Yansong Zhang. (2021) Reliability and toxicity of bevacizumab for neurofibromatosis type 2-related vestibular schwannomas: A systematic review and meta-analysis. American Journal of Otolaryngology 42:6, pages 103148.
Crossref
Amir Kaywan Aftahy, Maximilian Groll, Melanie Barz, Arthur Wagner, Nicole Lange, Vicki Marie Butenschön, Claire Delbridge, Denise Bernhardt, Bernhard Meyer, Chiara Negwer & Jens Gempt. (2021) Surgical Outcome of Trigeminal Schwannomas. Cancers 13:6, pages 1310.
Crossref
Longping Yao, Mohammed Alahmari, Yasin Temel & Koos Hovinga. (2020) Therapy of Sporadic and NF2-Related Vestibular Schwannoma. Cancers 12:4, pages 835.
Crossref
Gregory P. Lekovic, Marc S. Schwartz, George Hanna & John Go. (2018) Intra-Orbital Meningioma Causing Loss of Vision in Neurofibromatosis Type 2: Case Series and Management Considerations. Frontiers in Surgery 5.
Crossref
Abraham Jacob, Suzu Igarashi, Terry Platto, Rihan Khan & Richa Jain. (2015) The Solid Component of Radiographically Non-Growing, Post-Radiated Vestibular Schwannoma Retains Proliferative Capacity. Annals of Otology, Rhinology & Laryngology 124:10, pages 834-840.
Crossref
Jeremie Vitte & Marco Giovannini. 2015. Heat Shock Protein-Based Therapies. Heat Shock Protein-Based Therapies 257 271 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.